| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 171 |
| 1 | RISPERIDONE | 130 |
| 2 | GABAPENTIN | 114 |
| 3 | ETANERCEPT | 99 |
| 4 | ADALIMUMAB | 91 |
| 5 | LEVOTHYROXINE SODIUM | 91 |
| 6 | ERGOCALCIFEROL | 86 |
| 7 | TRASTUZUMAB | 86 |
| 8 | ACETAMINOPHEN | 72 |
| 9 | PREDNISONE | 71 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-TRYPTOPHAN | 24 | 0.0543 |
| 1 | TRASTUZUMAB-QYYP | 11 | 0.0282 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 39 | 0.0141 |
| 3 | CALCIUM CARBONATE ANTACID | 1 | 0.0130 |
| 4 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 5 | VITAMINS AND MINERALS | 1 | 0.0112 |
| 6 | CLOMIPRAMINE HYDROCHLORIDE | 28 | 0.0061 |
| 7 | ADO-TRASTUZUMAB EMTANSINE | 48 | 0.0057 |
| 8 | DROSPIRENONE AND ESTRADIOL | 3 | 0.0056 |
| 9 | METHENAMINE MANDELATE | 1 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 155 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 151 |
| 2 | Atypical Antipsychotic [EPC] | 145 |
| 3 | Estrogen [EPC] | 141 |
| 4 | Corticosteroid [EPC] | 135 |
| 5 | Benzodiazepine [EPC] | 106 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 100 |
| 7 | Aromatase Inhibitor [EPC] | 98 |
| 8 | Provitamin D2 Compound [EPC] | 86 |
| 9 | Vitamin D [EPC] | 74 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 20 | 0.0291 |
| 1 | Endoglycosidase [EPC] | 7 | 0.0038 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 3 | Provitamin D2 Compound [EPC] | 86 | 0.0029 |
| 4 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 100 | 0.0013 |
| 6 | Human Immunoglobulin G [EPC] | 28 | 0.0013 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 2 | 0.0012 |
| 8 | Aromatase Inhibitor [EPC] | 98 | 0.0009 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |